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Abstract
Individuals affected by NGLY1 Deficiency cannot properly deglycosylate and recycle certain
proteins. Even though less than 100 people worldwide have been diagnosed with this rare autosomal
recessive condition, thousands are affected by similar glycosylation disorders. Common phenotypic
manifestations of NGLY1 Deficiency include severe neural and intellectual delay, impaired muscle
and liver function, and seizures that may become intractable. Very little is currently known about
the various mechanisms through which NGLY1 deficiency affects the body and this has led to a
lack of viable treatment options for those afflicted. This experiment uses a loss-of-function (LOF)
mouse model of NGLY1 Deficiency homologous to a mutation observed in affected humans
that prematurely terminates the protein. Mouse pups with two LOF alleles are embryonic-lethal,
and we observe gross morphological effects in the liver and brain of these pups starting as early
as embryonic day 15.5 (E15.5). Given the potential for pharmaceutically improving cognitive
function post-diagnosis in humans, we focused on understanding the neurological gene expression.
Therefore, we harvested cortex and full brain tissue from littermates of a carrier cross at E14.5 to
acquire transcriptomes for gene expression analysis. NGLY1 gene counts displayed significant dose
dependency across the normal, carrier, and affected littermates with correlated effects in genes dealing
with glycosaminoglycan biosynthesis, as expected, and Wnt signaling pathways. Previous knowledge
of glycosaminoglycan biosynthesis and recent breakthroughs in treatments utilizing the Wnt signaling
pathway provide a foundation for future treatment investigations concerning NGLY1 Deficiency and
potentially other glycosylation disorders during development.
Introduction
NGLY1 Deficiency is a rare genetic disorder in

NGLY1 pathway interactions, leading to a lack of

which individuals lack the ability to successfully

supported drug treatments.

deglycosylate and recycle certain proteins (Suzuki et

Known pathway interactions include components

al., 2016). The phenotypes of this disease manifest

of the Endoplasmic Reticulum-Associated Degradation

in early childhood through delayed neural and

(ERAD) pathway (Enns et al., 2014). The ERAD

muscular development (Rare Diseases Clinical

pathway identifies misfolded proteins and degrades

Research Network). Less than 100 cases have been

them. NGLY1 encodes N-glycanase 1, which aids in

identified and therapeutic approaches are ineffective

the cytosolic degradation of these misfolded proteins.

in improving quality of life. Very little is known about

N-glycanase acts at the asparagine residues of N-liked
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proteins by cutting off the initial GlcNAc (Suzuki et

the NUSeq Core at Northwestern University. RNA

al., 2016). Mutations in this gene lead to an inability

sequencing provided .fastq files that were analyzed

to recycle the proteins and block protein recycling.

using the cloud-based program, BioJupies. The

Specific details of the role of NGLY1 in the ERAD

BioJupies analyses combined with further analysis of

pathway are still unclear. Transcriptomic identification

raw and normalized gene counts in Excel led to the

of drug targetable pathways in NGLY1 Deficiency

identification of pathways and individual genes that

have not been reported, though transcriptomic data

were downregulated in the mutants. Gene counts

have recently been published for a Drosophila model

were averaged for each phenotype and the differential

of the disorder and our group has generated both

expression was calculated. Reactome software

zebrafish and mouse transcriptomics. It is important

facilitated the creation of schematics that outlined

to gain insight into gene expression of a mammalian

the gene interactions between the most significantly

model of NGLY1 due to the lack of phenotype in

downregulated genes. Further literature research

zebrafish. Mouse models of NGLY1 are embryonic-

provided insight into possible explanations and

lethal which provide a druggable phenotype for future

hypotheses for unknown interactions.

research. The purpose of this experiment was to find
drug targetable pathways in an NGLY1 mouse model

Results

using ‘omics’ technology. Zebrafish transcriptomes

The BioJupies analysis of .fastq files containing

point to a downregulation of cholesterol biosynthesis

NGLY1 mouse RNA sequencing data showed

which was the acting hypothesis for this experiment.

glycosaminoglycan biosynthesis to be significantly

Transcriptomes were obtained through RNA

downregulated among the mutants. Various instances

sequencing of wildtype (WT), carrier (heterozygous),

of cell cycle and metabolic downregulation were also

and mutant brain tissue, then analyzed using BioJupies

noted. Wnt signaling was downregulated as well,

to find the upregulated and downregulated pathways

specifically in the canonical Wnt signaling pathway

across the unaffected (WT and heterozygous) and the

using β-catenin (Figure 1).

mutants (Torre et al., 2018).

Figure 1. Specific metabolic and growth pathways are
significantly downregulated in mutant mice. Analysis

Materials and Methods

of the transcriptomic data allowed the affected

Carrier crosses were conducted, and the pups

genes in the mutant animals to be classified as up-

were harvested at day E14.5. Whole brain and

regulated (highlighted in red) or down-regulated

cortex tissue were collected separately. The tissues

(highlighted in blue). The function of each transcript

were genotyped and subjected to 50bp single-end

was determined using the Gene Ontology Biological

sequencing on Illumina HiSeq 4000 platform at

Process (2018 version).
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Expression of NGLY1 displayed dose dependency

LogCPM gene counts for wild-type (WT, blue),

across the phenotypes (Figure 2). A similar dose

heterozygous (Het, orange), and mutant (Mut, gray)

dependency to that of NGLY1 was seen for transcripts

mice for genes associated with the Wnt signaling

RSPO2 and WNT2B, which are both implicated

pathway were plotted. The error bars represent the

in the Wnt signaling pathway (Figure 2). Although

standard error of the mean.

expression levels were decreased among mutants for

Figure 3 (see above). Canonical Wnt-signaling

most of the main genes involved in Wnt signaling,

pathway in the inactive and active states. In the

there was a lack of dose dependency for the majority.

inactive state, β-catenin is bound by the destruction

The expression level for WNT3A, a Wnt ligand, was

complex and eventually degraded by the proteasome.

decreased in mutants with greater disparity between

Ligand-bound receptors in the activate state sequester

mutant and WT than seen in NGLY1 itself (Figure

the destruction complex, which allows β-catenin to

2). FZD9, the WNT3A receptor, was decreased in

accumulate and translocate into the nucleus, where

mutants as well (Figure 2 and Figure 3).

it binds TCF/LEF transcription factors to stimulate
Wnt-signaling target genes. These genes encourage
cell growth and differentiation. (Figure generated
with Procreate software).
Dose dependency was less evident among
genes implicated in glucosaminoglycan (GAG)
biosynthesis (Figure 4). It is interesting to note
that B4GALT7 and B3GLAT6 showed increased
expression in mutants even though the pathway was
identified as downregulated. Other genes involved in
GAG biosynthesis did have lower expression levels

Figure 2. NGLY1 and Wnt signaling components

in mutants, but overall looked to be insignificant.

were dose dependent across the phenotypes examined.

BCAN and XYLT1, which carry out the initiation
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of the tetrasaccharide linkage formation, displayed

Discussion

lower levels of expression (Figure 5). Heparan sulfate

GAG biosynthesis and canonical Wnt signaling were

(HS) was identified by Gene Ontology and Reactome

found to be downregulated among NGLY1 deficient

as a major GAG affected by the downregulation of

mice. The original hypothesis of mutant mice

necessary biosynthetic genes (Figure 5).

experiencing cholesterol biosynthesis downregulation
was not supported as a main affected pathway.
However, cholesterol biosynthesis may be hidden
under the larger group of metabolic processes
indicated to be downregulated. Downregulation of
both Wnt signaling and GAG biosynthesis pathways
is known to display phenotypes like NGLY1 mutants.
Individually and synergistically, GAGs such as HS and
Wnt signaling are crucial to embryonic development.
Significant downregulation of both processes could

Figure 4. Glucosaminoglycan (GAG) biosynthesis

account for the embryonic lethality of the NGLY1

components did not have dose dependent expression

mutation when homozygous.

across the phenotypes examined. LogCPM gene

Through analysis of the biochemical structure

counts for wild-type (WT, blue), heterozygous (Het,

of the Wnt signaling components, their possible

orange), and mutant (Mut, gray) mice for NGLY1

interactions with NGLY1 become clearer. The Wnt-

and genes associated with the GAG biosynthesis

signaling pathway relies on Wnt ligands to cause

pathway were plotted. The error bars represent the

downstream sequestration of the β-catenin destruction

standard error of the mean.

complex by other membrane bound proteins. This

Figure 5. Interaction of genes identified by the Gene

is the mechanism by which β-catenin accumulates

Ontology Enrichment Analysis in production of the

within the cell and moves down its concentration

GAG heparan sulfate. Carbohydrates are added to

gradient into the nucleus (Komiya & Hapas, 2008).

the core protein using enzymes indicated by the black

The application of this mechanism has not been

ovals. (Figure generated using PowerPoint software).

studied in models of NGLY1 Deficiency. Therefore,
β-catenin nuclear localization may not be occurring
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as in normal models. The Wnt ligand, WNT3A,

(Shin et al., 2016). An inability to keep β-catenin in

is N-glycosylated at two asparagine (Asn) residues

the nucleus makes it less likely for the Wnt ligand

along the molecule. A study by Komekado and

stimulation to have any effect on Wnt target gene

colleagues demonstrated that glycosylation at Asn87

transcription. A PIN1 knockout mouse model

was critical for the secretion of WNT3A (2007). The

has significantly decreased nuclear β-catenin and

second N-glycosylation at Asn298 has little effect on

neuronal differentiation (Nakamura et al., 2012).

secretion when compared to the WT. Interestingly,

The same study was able to rescue wild-type neuronal

the lack of deglycosylation seen in NGLY1 deficiency

differentiation in neuronal progenitor cells through

should theoretically help Wnt ligand secretion, yet an

overexpression of β-catenin (Nakamura et al.,

overall downregulation of the canonical Wnt signaling

2012). With the downregulation of PIN1, decreased

pathway was seen. This may indicate other areas of

expression of Wnt signaling components downstream

malfunction in the pathway, or disruption of the

of the Fzd receptor are seen.
In terms of signaling and the binding of ligands

cycle of glycosylation all together. When dealing with
N-linked fucosylation of Wnt ligands in zebrafish,

to target receptors, Wnt ligands and GAGs like

Feng and colleagues discovered that increased levels of

HS are connected. Binari and colleagues studied a

Wnt N-fucosylation decreases Wnt signaling through

Drosophila model of kiwi mutants (1997). The kiwi

a negative feedback mechanism, as well as diminishes

gene codes for UDP-glucose dehydrogenase, which

the range of Wnt signaling all together (2014).

is a key player in GAG biosynthesis. They found

Although this study deals with fucosylation, it could

that the kiwi mutants have identical phenotypes

possibly explain the downregulation of Wnt signaling

to wingless (Wnt) mutants which alludes to the

without impaired secretion.

importance of GAGs in Wnt-mediated development.
More specifically, they were able to rescue wild-type

When looking at downstream Wnt target
genes, DPAGT1 is another possible mode of

cuticular development through supplementation of

negative feedback. DPAGT1 is a gene involved

HS. Wild-type individuals were given heparinase, a

in the regulation of the N-glycosylation pathway

heparan degrader, and displayed wingless phenotypes

(Vargas et al., 2016). After the initial decrease in Wnt

as well. HS modulates Wnt signaling by binding and

signaling due to excessive N-glycosylation of the Wnt

releasing Wnt ligands in variation (Gao et al., 2017).
Specific O-sulfations are needed for maximum

ligands, decreased DPAGT1 could propagate lower
glycosylation states in the cell. This may be a cause for

binding affinity of Wnt ligands (Gao et al., 2017).

subsequent issues in Wnt ligand secretion. RSPO2

Wnt molecules were found to have high affinities for

shows dose dependency like that of NGLY1. A study

HS chains with six to eight saccharide residues and

by Kim and colleagues demonstrated that RSPOs act

2-O, 3-O, and 6-O sulfations. In a study by Mii and

to amplify the Wnt ligand signal by inhibiting DKK1,

colleauges, clustering of HS along the cell surface by

a negative regulator of the Wnt pathway (2008).

N-sulfo-rich and N-acetyl-rich chains facilitates the
colocalization of Wnt ligands and associated receptors

The end goal of the canonical Wnt signaling
pathway is the facilitation of transcription of

(2020). Wnt ligands readily bind to N-sulfo-rich

downstream target genes through increased nuclear

HS proteoglycans and form signalosomes that are

b-catenin. Therefore, downregulation of PIN1 could

internalized and lead to the phosphorylation of

lead to an inability to retain nuclear β-catenin.

LRP5/6 (Bilic et al., 2007). Wnt ligand association

PIN1 is a prolyl isomerase that keeps β-catenin in

with N-acetyl-rich HS proteoglycans is implicated

the confirmation necessary to remain in the nucleus

in long range Wnt signaling (Mii et al., 2020).
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Downregulation of GAG biosynthesis decreases

the treatment of an NGLY1 model with a Wnt

the amount of HS available to assist Wnt ligands

agonist could provide insight into the sensitivity of

in binding target receptors. HS proteoglycans also

the downstream signaling components experiencing

play a role in axon guidance and synapse function

downregulation. A study by Chai and colleagues

(Condomitti and de Wit, 2018).

found that structural birth defects in a mouse model

Heparan Sulfate Proteoglycans (HSPGs) are

of deficient Wnt secretion could be overcome using

some of the largest glycosylated proteins. They

a Wnt agonist (2021). They were able to rescue the

consist of a core protein, a tetrasaccharide linkage,

development of vertebrate within the mutant tails.

and a GAG region with many possible biochemical

If developmental delay of NGLY1 models can be

modifications. The gene expression data for BCAN,

overcome with Wnt agonist supplementation, future

the gene encoding the brevican core protein of

use in humans may provide a simple drug treatment

HSPGs, was downregulated in mutants (Figure 4).

for the afflicted children and their families.

The mutants may be downregulating biosynthesis of

In conclusion, although the original hypothesis

core proteins due to the low levels of available GAGs

stating that cholesterol biosynthesis would be

for use in building larger proteoglycans. Furthermore,

downregulated in mutants was not supported, GAG

we propose a new biochemical function for NGLY1

biosynthesis and Wnt signaling were downregulated.

cleavage at the tetrasaccharide linkage. The use

Heparin sulfate is a GAG implicated in Wnt

of lectins to identify the presence of key HSPG

signaling. With continued investigation, targeting

structures post-exposure to NGLY1 could be used to

Wnt signaling using a Wnt agonist could provide

test the proposed interaction.

an inexpensive and direct way to treat NGLY1

Limitations of this study include the small

Deficiency and a possible future treatment option for

sample size and stress responses after the harvest

the children affected by this disorder.

that influence transcription levels. Moving forward,
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